🇺🇸 Anti-TNFα continued perioperatively in United States

Anti-TNFα continued perioperatively (Anti-TNFα continued perioperatively) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Anti-TNFα continued perioperatively in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Anti-TNFα continued perioperatively approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Anti-TNFα continued perioperatively in United States?

CHU de Quebec-Universite Laval is the originator. The local marketing authorisation holder may differ — check the official source linked above.